ARIAD Pharmaceuticals' IPO

ARIAD Pharmaceuticals raised a round of funding on May 24, 1994. Investors include Public.

ARIAD is developing breakthrough medicines that regulate cell-signaling pathways implicated in cancer. Our pipeline includes a series of small molecule product candidates that provide targeted and hig…

Articles about ARIAD Pharmaceuticals' IPO: